RHINO THERAPEUTICS LIMITED
14604755Research and experimental development on biotechnology
RHINO THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
Fourth Floor St James House St James' Square Cheltenham GL50 3PR England
Full company profile for RHINO THERAPEUTICS LIMITED (14604755), an active life sciences and medical technology company based in Cheltenham, England. Incorporated 19 Jan 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2023–2025)
Cash in Bank
£745.18k
Net Assets
£1.20M
Total Liabilities
£973.28k
Turnover
N/A
Employees
2
Debt Ratio
45%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Dec Year End | 2025 31 Mar Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Xanthopoulos, Kleanthis Gabriel | Director | American | United States | 23 Feb 2026 | Active |
See all 4 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Graham Michael Wynne
Ceased 18 Jul 2023
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 6 May 2026 | Accounts | Annual accounts made up to 31 Dec 2025 | |
| 14 Apr 2026 | Officers | Termination of Andrew William Mulvaney as director on 1 Dec 2025 | |
| 14 Apr 2026 | Officers | Appointment of Dr Andrew William Mulvaney as director on 2 Feb 2026 | |
| 4 Mar 2026 | Officers | Appointment of Mr Kleanthis Gabriel Xanthopoulos as director on 23 Feb 2026 | |
| 3 Mar 2026 | Officers | Termination of Graham Michael Wynne as director on 23 Feb 2026 |
Annual accounts made up to 31 Dec 2025
Termination of Andrew William Mulvaney as director on 1 Dec 2025
Appointment of Dr Andrew William Mulvaney as director on 2 Feb 2026
Appointment of Mr Kleanthis Gabriel Xanthopoulos as director on 23 Feb 2026
Termination of Graham Michael Wynne as director on 23 Feb 2026
Recent Activity
Latest Activity
Annual accounts made up to 31 Dec 2025
1 months ago on 6 May 2026
Termination of Andrew William Mulvaney as director on 1 Dec 2025
2 months ago on 14 Apr 2026
Appointment of Dr Andrew William Mulvaney as director on 2 Feb 2026
2 months ago on 14 Apr 2026
Appointment of Mr Kleanthis Gabriel Xanthopoulos as director on 23 Feb 2026
3 months ago on 4 Mar 2026
Termination of Graham Michael Wynne as director on 23 Feb 2026
3 months ago on 3 Mar 2026